Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
Titel:
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
Auteur:
Wu, Yi-Long Sequist, Lecia V. Tan, Eng-Huat Geater, Sarayut L. Orlov, Sergey Zhang, Li Lee, Ki Hyeong Tsai, Chun-Ming Kato, Terufumi Barrios, Carlos H. Schuler, Martin Hirsh, Vera Yamamoto, Nobuyuki O’Byrne, Kenneth Boyer, Michael Mok, Tony Peil, Barbara Märten, Angela Chih-Hsin Yang, James Paz-Ares, Luis Park, Keunchil